Blog

Better Buy: Amgen vs. Johnson & Johnson

If you're the kind of investor who likes to go big or go home, Amgen (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ) might be right up your alley. Amgen ranks as the biggest biotech in terms of

TheMotleyFool

0

Apple Stock: Buy, Sell, or Hold?

While many stocks have rebounded sharply since the coronavirus market crash in February and March, some still remain well below recent highs. Apple (NASDAQ: AAPL) is one of those stocks. Shares are

TheMotleyFool

0

3 Things to Consider Before Raiding Your Retirement Fund to Pay the Bills

The coronavirus pandemic has turned the world upside down, wreaking havoc on people's health, the world economy, and job security.

Approximately 22 million Americans have filed for unemployment

TheMotleyFool

0

3 Top Growth Stocks to Buy Right Now

There's no better way to earn life-changing wealth in the stock market than growth investing. Well-chosen growth stocks can deliver returns of 10, 20, and even 100 times or more your original

TheMotleyFool

0

Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works.

When Pfizer (NYSE: PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared to their highest point

TheMotleyFool

0

Trulieve Rolls Toward a Strong Position in the Pot Industry

Trulieve (OTC: TCNNF), a Florida-based seed-to-sale company with 46 medical marijuana dispensaries in the Sunshine State, has been able to adjust smoothly to varying customer demand posed by the

TheMotleyFool

0

These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?

An initial public offering (IPO) has a special allure: It draws in speculative investors eager to see stocks soar in the initial days of trading. In weak markets, only the strongest candidates pull

TheMotleyFool

0

Didn't Get a Coronavirus Stimulus Check? Here's How to Fix It

Most Americans with income under qualifying rates will receive a coronavirus stimulus check (technically, an "Economic Impact Payment," and in most cases, it will come as a direct deposit and not a

TheMotleyFool

0

Better Buy: AbbVie vs. Gilead Sciences

AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) are names you might be hearing a lot these days. AbbVie is in the process of acquiring Botox maker Allergan (NYSE: AGN) to boost its growth

TheMotleyFool

0

2020 Social Security Trustees Report: 5 Must-Know Facts About Your Retirement Benefits

The coronavirus pandemic has pushed other, less immediate worries into the background, as everyone from government officials to first responders and ordinary people do what they can to protect

TheMotleyFool

0

3 401(k) Mistakes to Avoid During the COVID-19 Crisis

Millions of Americans have already been impacted financially by COVID-19, and if you're one of them, that could change the way you plan and save for retirement. But the more careful you are with

TheMotleyFool

0

3 Warren Buffett Stocks to Avoid at All Costs

While debatable, there's probably not a more revered investor than Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. Having begun with $10,000 in seed capital in the 1950s, Buffett

TheMotleyFool

0

5 Small Bank Stocks That Could Do Well During a Downturn

The coronavirus pandemic has had an outsized effect on the banking sector, as lenders brace for loan losses brought on by the economic shutdown. As of Wednesday's close, the KRE regional bank index

TheMotleyFool

0

5 Smart Stocks to Buy During a Stock Market Crash

As you've probably learned one way or another over the past two months, stock market corrections, and even bear markets (i.e., declines of at least 20% from a recent high), are an inevitable part of

TheMotleyFool

0